Loading clinical trials...
Loading clinical trials...
To evaluate the long-term maintenance of response, safety and tolerability of repeated administration of adalimumab in subjects with Crohn's disease who participated in and successfully completed Prot...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Abbott
NCT07184931 · Crohn's Disease
NCT06100289 · Ulcerative Colitis, Crohn's Disease
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT06180382 · Crohn's Disease
NCT07545317 · Crohn's Disease
Site Ref # / Investigator 1894
Huntsville, Alabama
Site Ref # / Investigator 1895
Jacksonville, Alabama
Site Ref # / Investigator 1787
La Jolla, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions